NCT00796614View on ClinicalTrials.gov

Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

231

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Bladder, Neurogenic
Interventions
DRUG

tamsulosin hydrochloride

Oral

DRUG

Placebo

Oral

Trial Locations (52)

1000

Manila

1104

Quezon City

1604

Pasig

7700

Cape Town

9000

Ghent

9300

Bloemfontein

10115

Berlin

10591

Tarrytown

14222

Buffalo

22763

Hamburg

27157

Winston-Salem

28046

Madrid

29011

Málaga

33614

Tampa

37660

León

44308

Akron

45122

Essen

50139

Florence

55101

Mainz

58002

Chernivtsy

63110

St Louis

72190

Puebla City

90027

Los Angeles

94469

Deggendorf

119991

Moscow

194100

Saint Petersburg

09060-650

Santo André

05403-000

São Paulo

380-006

Ahmedabad

590-010

Belagavi

560-010

Bengaluru

500-029

Hyderabaad

682-026

Kochi

226-014

Lucknow

Unknown

Ludhiana

Nagpur

Johannesburg

Roodepoort

Seoul

576-104

Manipal

400-008

Mumbai

387-001

Nadiād

110-029

New Delhi

411-001

Pune

411-053

Pune

09134

Cagliari

00165

Roma

0028

Pretoria

501-757

Gwangju

400-711

Incheon

602-739

Pusan

08025

Barcelona

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00796614 - Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder | Biotech Hunter | Biotech Hunter